GTX-102 Leads to Significant Improvements in Trial, But Also Causes Muscle Weakness
News
Use of GTX-102, GeneTx Biotherapeutics and Ultragenyx’s investigational therapy for Angelman syndrome, led to substantial improvements in disease symptoms among children and adolescents across several treatment areas — including ... Read more